Johnson & Johnson

$JNJ

146
fundamentals:

from the start of 2013 to the present...

price: +49.96%

revenues: +7.42%

on the other hand, free cash flow is down from 10.105B in Q3, 2010 to 7.974B for Q2, 2014


technicals:

the monthly Williams %R hasn't been below -80 since mid-late 2010.

this is indicative of positive pressure.

免责声明

这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。